Published in Lung Cancer on May 25, 2007
DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol Cancer (2008) 1.55
Molecular biology of lung cancer: clinical implications. Clin Chest Med (2011) 1.47
Epigenetic effects of lung cancer predisposing factors impact on clinical diagnosis and prognosis. J Cell Mol Med (2008) 0.97
Epigenetics of lung cancer. Transl Res (2014) 0.95
Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis. PLoS One (2013) 0.88
Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis. PLoS One (2011) 0.87
Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer. Clin Epigenetics (2014) 0.86
CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer. J Thorac Oncol (2013) 0.86
Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation. Mol Cells (2013) 0.83
Hypomethylation of the thymosin β(10) gene is not associated with its overexpression in non-small cell lung cancer. Mol Cells (2011) 0.81
Nuclear translocation of Acinetobacter baumannii transposase induces DNA methylation of CpG regions in the promoters of E-cadherin gene. PLoS One (2012) 0.81
MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases. Oncol Rep (2011) 0.80
Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer. Oncotarget (2016) 0.78
Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis. PLoS One (2013) 0.78
The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review. Drug Des Devel Ther (2016) 0.76
The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review. Sci Rep (2016) 0.76
The clinicopathological significance of hMLH1 hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review. Onco Targets Ther (2016) 0.75
Tumour biomarkers: homeostasis as a novel prognostic indicator. Open Biol (2016) 0.75
Telomere length and the risk of lung cancer. Cancer Sci (2008) 2.35
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet (2012) 2.26
Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol (2005) 2.09
The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet (2010) 1.90
Septic pulmonary embolism in Korea: Microbiology, clinicoradiologic features, and treatment outcome. J Infect (2006) 1.58
Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin. J Biol Chem (2002) 1.53
Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol (2008) 1.50
Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers. J Thorac Oncol (2010) 1.43
DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis (2004) 1.37
Chronic bacterial seminal vesiculitis as a potential disease entity in men with chronic prostatitis. Int J Urol (2015) 1.37
Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J Control Release (2003) 1.34
Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res (2008) 1.32
Identification of the alphavbeta3 integrin-interacting motif of betaig-h3 and its anti-angiogenic effect. J Biol Chem (2003) 1.31
Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.29
PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers. Lung Cancer (2009) 1.22
EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Cancer Genet Cytogenet (2007) 1.20
Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer (2007) 1.19
RGD peptides released from beta ig-h3, a TGF-beta-induced cell-adhesive molecule, mediate apoptosis. Oncogene (2003) 1.19
Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res (2012) 1.18
TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis. Am J Respir Cell Mol Biol (2005) 1.17
Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum Mol Genet (2006) 1.17
Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet (2006) 1.14
Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis. PLoS Genet (2011) 1.12
Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Cancer (2007) 1.11
CNT/PDMS composite flexible dry electrodes for long-term ECG monitoring. IEEE Trans Biomed Eng (2012) 1.10
Clinical aspects of rifampicin-associated pseudomembranous colitis. J Clin Gastroenterol (2007) 1.09
Low-dose persistent organic pollutants increased telomere length in peripheral leukocytes of healthy Koreans. Mutagenesis (2010) 1.09
microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3. Exp Ther Med (2011) 1.07
Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev (2002) 1.07
Polymorphisms in TGF-beta1 gene and the risk of lung cancer. Lung Cancer (2006) 1.05
Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J (2008) 1.05
XPC polymorphisms and lung cancer risk. Int J Cancer (2005) 1.03
Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology (2012) 1.02
MDM2 309T>G polymorphism and risk of lung cancer in a Korean population. Lung Cancer (2006) 1.02
Technical and oncologic safety of robotic thyroid surgery. Ann Surg Oncol (2013) 1.01
Polymorphisms in telomere maintenance genes and risk of lung cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.00
Expression of TGF-beta-induced matrix protein betaig-h3 is up-regulated in the diabetic rat kidney and human proximal tubular epithelial cells treated with high glucose. Kidney Int (2003) 1.00
Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer. Lung Cancer (2011) 1.00
Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy. Biomol Ther (Seoul) (2013) 0.99
A follow-up of integrated positron emission tomography/computed tomography after curative resection of non-small-cell lung cancer in asymptomatic patients. J Thorac Cardiovasc Surg (2009) 0.99
Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer. J Clin Oncol (2009) 0.99
Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy. Lung Cancer (2013) 0.98
betaig-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through alphavbeta5 integrin. Exp Mol Med (2006) 0.98
Radiation exposure to the surgeon during percutaneous endoscopic lumbar discectomy: a prospective study. Spine (Phila Pa 1976) (2013) 0.98
Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia. J Infect (2012) 0.97
Up-regulated transforming growth factor beta-inducible gene h3 in rheumatoid arthritis mediates adhesion and migration of synoviocytes through alpha v beta3 integrin: Regulation by cytokines. Arthritis Rheum (2006) 0.97
Association of a common AGO1 variant with lung cancer risk: a two-stage case-control study. Mol Carcinog (2010) 0.97
-93G-->A polymorphism of hMLH1 and risk of primary lung cancer. Int J Cancer (2004) 0.97
The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations. Hum Genet (2011) 0.96
Diagnostic performance of the QuantiFERON-TB Gold In-Tube assay and factors associated with nonpositive results in patients with miliary tuberculosis. Clin Infect Dis (2014) 0.96
Inhibitory effect of Jeju endemic seaweeds on the production of pro-inflammatory mediators in mouse macrophage cell line RAW 264.7. J Zhejiang Univ Sci B (2010) 0.96
A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. Lung Cancer (2010) 0.95
Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study. BMC Cancer (2007) 0.95
Focal necrotizing pneumonia is a distinct entity from lung abscess. Respirology (2013) 0.95
Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population. Lung Cancer (2006) 0.95
Comparison of costs for video-assisted thoracic surgery lobectomy and open lobectomy for non-small cell lung cancer. Surg Endosc (2010) 0.95
A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population. Gene (2013) 0.94
Nodular fasciitis in the submandibular gland. Diagn Cytopathol (2008) 0.94
Multidrug resistance-1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia. Int J Cancer (2006) 0.93
Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology (2007) 0.93
Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer. Clin Cancer Res (2009) 0.93
Factors influencing residual pleural opacity in tuberculous pleural effusion. J Korean Med Sci (2008) 0.93
EML4-ALK fusion gene in Korean non-small cell lung cancer. J Korean Med Sci (2012) 0.93
Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer. Mol Carcinog (2007) 0.92
Purification and characterization of prodigiosin produced by integrated bioreactor from Serratia sp. KH-95. J Biosci Bioeng (2006) 0.92
EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling. Cell Mol Life Sci (2014) 0.92
MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer. Jpn J Clin Oncol (2006) 0.92
Primary esophageal repair in Boerhaave's syndrome. Dis Esophagus (2008) 0.92
Effects of albumin and Ringer's lactate on production of lung cytokines and hydrogen peroxide after resuscitated hemorrhage and endotoxemia in rats. Crit Care Med (2003) 0.91
Associations of organochlorine pesticides and polychlorinated biphenyls in visceral vs. subcutaneous adipose tissue with type 2 diabetes and insulin resistance. Chemosphere (2013) 0.91
Venous thromboembolism in Korean patients undergoing major orthopedic surgery: a prospective observational study using computed tomographic (CT) pulmonary angiography and indirect CT venography. J Korean Med Sci (2009) 0.91
Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features. Cancer Sci (2006) 0.91
Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study. BMC Cancer (2006) 0.91